Part of the MRC translational research strategy and provides annual awards of £250k-£1.2m to be used flexibly to support the earliest stages of multiple translational research projects.
Read more
A team at The University of Manchester have found that the standard treatment for asthma - oral steroids - was associated with increased levels of the treatable mould Aspergillus in the lung.
Read more
MAHSC Inflammation & Repair and Cardiovascular Domains is funding the programme fees for two project teams on Haelo’s 2018-19 Improvement Science for Leaders programme
Read more
An international team of scientists and doctors has identified a family of five new genetic diseases which are likely to affect more than 1 in 5000 children.
Read more
We'd like to say a massive thank you to everyone who participated in, delivered or supported research at Manchester University NHS Foundation Trust during 2017.
Read more
At the start of 2017 teams were challenged to pursue as many first patients recruited to commercially sponsored trials as they could, whether first global, European or UK. Find out how well they did!
Read more
The World Health Organization (WHO) is recommending early use of tranexamic acid to treat bleeding post childbirth after fresh analysis of the WOMAN trial was published in The Lancet.
Read more
The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human. It successfully lowered the level of the harmful huntingtin protein the nervous system.
Read more
